Hapvida Participações e Investimentos Future Growth

Future criteria checks 3/6

Hapvida Participações e Investimentos is forecast to grow earnings and revenue by 50.3% and 8.1% per annum respectively. EPS is expected to grow by 62.1% per annum. Return on equity is forecast to be 5.8% in 3 years.

Key information

50.3%

Earnings growth rate

62.1%

EPS growth rate

Healthcare earnings growth	0%
Revenue growth rate	8.1%
Future return on equity	5.8%
Analyst coverage	Good
Last updated	18 Sep 2024

Recent future growth updates

No updates

Recent updates

No updates

Earnings and Revenue Growth Forecasts

BASE:HAPV3 - Analysts future estimates and past financials data (BRL Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	34,515	1,743	3,537	5,208	9
12/31/2025	31,674	1,149	3,022	4,552	10
12/31/2024	29,049	437	3,089	3,433	9
6/30/2024	27,335	-555	2,290	2,753	N/A
3/31/2024	27,976	-461	2,184	2,585	N/A
12/31/2023	27,770	-759	1,923	2,335	N/A
9/30/2023	15,641	-1,993	1,392	1,968	N/A
6/30/2023	15,080	-1,751	871	1,523	N/A
3/31/2023	20,085	-1,776	722	1,420	N/A
12/31/2022	23,812	-1,720	236	972	N/A
9/30/2022	19,845	-261	108	922	N/A
6/30/2022	16,083	-252	-37	744	N/A
3/31/2022	12,402	166	-492	236	N/A
12/31/2021	9,883	498	-457	252	N/A
9/30/2021	9,558	389	-177	293	N/A
6/30/2021	9,125	595	-36	413	N/A
3/31/2021	8,799	769	794	1,220	N/A
12/31/2020	8,555	783	960	1,326	N/A
9/30/2020	8,067	901	837	1,199	N/A
6/30/2020	7,256	865	850	1,173	N/A
3/31/2020	6,456	809	502	765	N/A
12/31/2019	5,634	850	383	657	N/A
9/30/2019	5,060	875	520	772	N/A
6/30/2019	4,908	852	353	578	N/A
3/31/2019	4,411	714	352	591	N/A
12/31/2018	4,576	787	310	517	N/A
9/30/2018	4,408	1,201	386	558	N/A
3/31/2018	4,383	768	N/A	608	N/A
12/31/2017	3,848	649	N/A	619	N/A
12/31/2016	3,036	457	N/A	484	N/A
12/31/2015	2,459	301	N/A	357	N/A
12/31/2014	1,964	270	N/A	334	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HAPV3 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (8.5%).

Earnings vs Market: HAPV3 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: HAPV3 is expected to become profitable in the next 3 years.

Revenue vs Market: HAPV3's revenue (8.1% per year) is forecast to grow slower than the AR market (12.1% per year).

High Growth Revenue: HAPV3's revenue (8.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: HAPV3's Return on Equity is forecast to be low in 3 years time (5.8%).